Close Menu

In this week's PNAS Early Edition, an international research team reports the interactions between the Jumonji C domain-containing hydroxylase JMJD6 and single-stranded RNA. Based on its molecular morphology, the investigators found that JMJD6 binds to single-stranded RNA, but not single-stranded DNA, double-stranded RNA, or double-stranded DNA, suggesting that the molecule is more likely to bind and modify single-strand RNA "rather than the previously reported peptide substrates."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.